Colgate-Palmolive (CL) – Investment Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Colgate-Palmolive (NYSE: CL) in the last few weeks:

• 5/5/2026 – Colgate-Palmolive had its price target raised by Barclays PLC from $79.00 to $80.00. They now have an “equal weight” rating on the stock.
• 5/4/2026 – Colgate-Palmolive was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 5/4/2026 – Colgate-Palmolive had its price target raised by UBS Group AG from $98.00 to $100.00. They now have a “buy” rating on the stock.
• 5/4/2026 – Colgate-Palmolive had its “buy” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have a $99.00 price target on the stock.
• 5/4/2026 – Colgate-Palmolive had its “overweight” rating reaffirmed by Morgan Stanley.
• 5/4/2026 – Colgate-Palmolive had its price target raised by JPMorgan Chase & Co. from $95.00 to $96.00. They now have an “overweight” rating on the stock.
• 5/4/2026 – Colgate-Palmolive had its “outperform” rating reaffirmed by Royal Bank Of Canada. They now have a $102.00 price target on the stock.
• 5/1/2026 – Colgate-Palmolive had its “buy” rating reaffirmed by The Goldman Sachs Group, Inc..
• 4/23/2026 – Colgate-Palmolive had its price target lowered by Morgan Stanley from $100.00 to $95.00. They now have an “overweight” rating on the stock.
• 4/21/2026 – Colgate-Palmolive was given a new $100.00 price target by Rothschild & Co Redburn. They now have a “buy” rating on the stock.
• 4/21/2026 – Colgate-Palmolive was upgraded by Rothschild & Co Redburn from “hold” to “buy”. They now have a $100.00 price target on the stock, up from $93.00.
• 4/17/2026 – Colgate-Palmolive had its price target lowered by JPMorgan Chase & Co. from $97.00 to $95.00. They now have an “overweight” rating on the stock.
• 4/14/2026 – Colgate-Palmolive had its price target lowered by Barclays PLC from $88.00 to $79.00. They now have an “equal weight” rating on the stock.
• 4/10/2026 – Colgate-Palmolive had its price target lowered by Bank of America Corporation from $105.00 to $102.00. They now have a “buy” rating on the stock.
• 4/9/2026 – Colgate-Palmolive was given a new $102.00 price target by Royal Bank Of Canada.
• 4/8/2026 – Colgate-Palmolive had its price target lowered by Wells Fargo & Company from $100.00 to $92.00. They now have an “equal weight” rating on the stock.
• 4/8/2026 – Colgate-Palmolive had its price target lowered by Piper Sandler from $96.00 to $92.00. They now have an “overweight” rating on the stock.
• 4/7/2026 – Colgate-Palmolive had its price target lowered by UBS Group AG from $100.00 to $98.00. They now have a “buy” rating on the stock.
• 3/31/2026 – Colgate-Palmolive had its “hold” rating reaffirmed by TD Cowen. They now have a $85.00 price target on the stock.
• 3/30/2026 – Colgate-Palmolive was upgraded by Deutsche Bank Aktiengesellschaft from “hold” to “buy”. They now have a $98.00 price target on the stock, up from $90.00.
• 3/29/2026 – Colgate-Palmolive was downgraded by Wall Street Zen from “buy” to “hold”.
• 3/21/2026 – Colgate-Palmolive was upgraded by Wall Street Zen from “hold” to “buy”.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.